Page last updated: 2024-09-05

sb 203580 and Bright Disease

sb 203580 has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harper, L; Hewins, P; Holden, N; Morgan, MD; Neil, D; Savage, CO; Williams, JM	1

Other Studies

1 other study(ies) available for sb 203580 and Bright Disease

Article	Year
IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney international, 2006, Volume: 69, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Blotting, Western; Female; Glomerulonephritis; Humans; Imidazoles; Immunohistochemistry; Indoles; Interleukin-18; Kidney; Macrophages; Male; Middle Aged; Neutrophil Activation; Neutrophils; p38 Mitogen-Activated Protein Kinases; Podocytes; Pyridines; Superoxides; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2006

Article

Year

IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis.

Kidney international, 2006, Volume: 69, Issue:3

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Blotting, Western; Female; Glomerulonephritis; Humans; Imidazoles; Immunohistochemistry; Indoles; Interleukin-18; Kidney; Macrophages; Male; Middle Aged; Neutrophil Activation; Neutrophils; p38 Mitogen-Activated Protein Kinases; Podocytes; Pyridines; Superoxides; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation

2006